Ophthalmology Times

6 days ago | ophthalmologytimes.com | Jordana Joy

The Tear Film and Ocular Surface Society (TFOS) DEWS III Digest Report, published in June 2025 in American Journal of Ophthalmology, has identified key research published since the 2017 TFOS DEWS II Workshop reports in the form of sex, gender, and hormones; epidemiology; pathophysiology; tear film; pain and sensation; iatrogenic; and clinical trial design.1 The report was comprised in an effort to support evidence cited in the TFOS DEWS III Diagnostic Methodology and Management and Therapy...

6 days ago | ophthalmologytimes.com | Jordana Joy

The Ontario Health Coalition and patients in Ontario announced during a press conference that they have filed formal complaints on behalf of patients charged user fees for health care in private clinics.1 The coalition has gathered evidence such as proof of payment and patient reports from 50 patients for the formal complaint, with the coalition receiving more than 200 complaints over the last year, according to a news release.

1 week ago | ophthalmologytimes.com | Jordana Joy

Heidelberg Engineering has announced the launch of ZinserLab, an innovation hub that will focus on accelerating the development of imaging technologies in eye care.1 The hub is named in honor of the company’s late cofounder Gerhard Zinser, PhD, according to a news release. “Gerhard Zinser was instrumental in building Heidelberg Engineering’s reputation for precision, excellence, and purpose.

1 week ago | ophthalmologytimes.com | Arshad Khanani |Sydney M Crago |Martin Harp

Author(s):,Arshad Khanani, MD, MA, FASRS, discussed the upcoming Clinical Trials Summit (CTS) 2025 meeting, which has become a key event in the ophthalmology and retina research calendar. This fifth-year anniversary meeting marks a notable expansion, with increased participation from clinicians, researchers, investors, venture capitalists, and Contract Research Organizations (CROs).

1 week ago | ophthalmologytimes.com | Lynda Charters

A recent Ophthalmology Times Case-Based Roundtable® tackled the topic of treating Demodex blepharitis and ocular surface disease (OSD) to maximize visual outcomes. Christopher E. Starr, MD, an associate professor of ophthalmology with Weill Cornell Medicine in New York, New York, described his pearls for treating affected patients. Case 1Starr described the case of a 74-year-old woman being evaluated before cataract surgery.